-+ 0.00%
-+ 0.00%
-+ 0.00%

ACR 2026: DAPIROLIZUMAB PEGOL ASSOCIATED WITH GREATER TREATMENT RESPONSE RATES VERSUS PLACEBO IN SLE USING NOVEL TREATMENT RESPONSE MEASURE

Reuters·11/09/2026 06:00:00

Please log in to view news